Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,583 | 221,804 | 30,133 | 24,839 | 85,367 |
| Marketable Securities | 171,910 | 36,900 | 46,400 | 40,770 | 0 |
| Receivables | 846 | 661 | 327 | 68 | 75 |
| Other current assets | 1,782 | 2,563 | 640 | 1,360 | 3,771 |
| TOTAL | $322,372 | $265,247 | $78,769 | $67,903 | $90,503 |
| Non-Current Assets | |||||
| PPE Net | 30,881 | 23,215 | 13,935 | 15,513 | 15,387 |
| Investments And Advances | 137,487 | 44,176 | 0 | 0 | 0 |
| Intangibles | 15,363 | 17,064 | 18,764 | 20,464 | 22,165 |
| Other Non-Current Assets | 16,401 | 144 | 142 | 142 | 122 |
| TOTAL | $200,132 | $84,599 | $32,841 | $36,119 | $37,674 |
| Total Assets | $522,504 | $349,845 | $111,610 | $104,022 | $128,177 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,829 | 7,650 | 2,806 | 4,077 | 12,233 |
| Accrued Expenses | 13,450 | 11,461 | 8,981 | 7,964 | 8,557 |
| Other current liabilities | 17 | 17 | 46 | 742 | 1,649 |
| TOTAL | $40,682 | $97,071 | $12,365 | $18,701 | $25,644 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,101 | 2,325 | 2,534 |
| Deferred Revenues | 19,291 | 77,944 | 308 | 5,710 | 3,010 |
| Other Non-Current Liabilities | 20,043 | 0 | 200 | 200 | 200 |
| TOTAL | $20,043 | $8,739 | $4,004 | $4,454 | $7,509 |
| Total Liabilities | $60,725 | $105,809 | $16,369 | $23,155 | $33,152 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,757 | 95,708 | 92,225 | 74,828 | 74,173 |
| Common Shares | 195 | 188 | 181 | 167 | 162 |
| Retained earnings | -503,844 | -419,291 | -487,266 | -432,815 | -398,435 |
| Other shareholders' equity | 18 | -947 | -577 | -522 | -548 |
| TOTAL | $461,779 | $244,036 | $95,241 | $80,867 | $95,024 |
| Total Liabilities And Equity | $522,504 | $349,846 | $111,610 | $104,022 | $128,176 |